Becton, Dickinson and Co. | BDX - Assets



Becton, Dickinson and Co. reported $57.29B in Assets for its fiscal quarter ending in September of 2024.

Assets Change Date
Abbott USD 74.36B 1.34B Sep/2024
Agilent USD 11.85B 850M Oct/2024
Align Technology USD 6.37B 207.65M Sep/2024
Avanos Medical USD 1.66B 1.6M Sep/2024
Baxter International USD 26.68B 364M Sep/2024
Becton, Dickinson and Co. USD 57.29B 1.7B Sep/2024
Bio-Rad Laboratories USD 10.6B 915.02M Sep/2024
Boston Scientific USD 38.08B 970M Sep/2024
Cooper Companies USD 12.11B 60.6M Jul/2024
Danaher USD 80.62B 2.06B Sep/2024
Dentsply International USD 6.63B 271M Sep/2024
Dexcom USD 6.35B 445.4M Sep/2024
Edwards Lifesciences USD 12.97B 2.87B Sep/2024
Exact Sciences USD 6.75B 75.27M Sep/2024
Globus Medical USD 5.09B 92.25M Sep/2024
Hologic USD 9.16B 265.9M Sep/2024
Insulet USD 3.03B 143.8M Sep/2024
Integra LifeSciences USD 4.07B 8.69M Sep/2024
Intuitive Surgical USD 17.74B 1.09B Sep/2024
J&J USD 178.29B 2.8B Sep/2024
Masimo USD 3.09B 193.9M Sep/2024
Medtronic USD 90.04B 293M Oct/2024
Patterson Companies USD 2.87B 0 Jul/2024
Stryker USD 43.83B 4.7B Sep/2024
Tandem Diabetes Care USD 957.73M 20.23M Sep/2024
Teleflex USD 7.49B 1000 Oct/2024
Terumo JPY 1.75T 116.7B Sep/2024
Thermo Fisher Scientific USD 100.36B 1.87B Sep/2024
Zimmer Biomet Holdings USD 21.72B 200.3M Sep/2024